{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:34:32Z","timestamp":1791488072514,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.vaccine.2012.12.071","type":"journal-article","created":{"date-parts":[[2013,1,10]],"date-time":"2013-01-10T17:47:08Z","timestamp":1357840028000},"page":"1312-1319","source":"Crossref","is-referenced-by-count":41,"title":["Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis"],"prefix":"10.1016","volume":"31","author":[{"given":"Laura","family":"Ram\u00edrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego M.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana P.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo A.F.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldina","family":"Barral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta R.","family":"Escutia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Bonay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila I.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9185","key":"10.1016\/j.vaccine.2012.12.071_bib0005","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.vaccine.2012.12.071_bib0010","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host\u2013pathogen interface","volume":"9","author":"Kaye","year":"2011","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2012.12.071_bib0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/0974-777X.62876","article-title":"Immunological perspectives of leishmaniasis","volume":"2","author":"Nylen","year":"2010","journal-title":"J Glob Infect Dis"},{"issue":"10\u201311","key":"10.1016\/j.vaccine.2012.12.071_bib0020","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.micinf.2008.06.002","article-title":"Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice","volume":"10","author":"Iborra","year":"2008","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2012.12.071_bib0025","doi-asserted-by":"crossref","first-page":"181690","DOI":"10.1155\/2010\/181690","article-title":"BALB\/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge","volume":"2010","author":"Ramirez","year":"2010","journal-title":"J Biomed Biotechnol"},{"issue":"12\u201313","key":"10.1016\/j.vaccine.2012.12.071_bib0030","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.micinf.2010.06.008","article-title":"Vaccination with the Leishmania infantum ribosomal proteins induces protection in BALB\/c mice against Leishmania chagasi and Leishmania amazonensis challenge","volume":"12","author":"Chavez-Fumagalli","year":"2010","journal-title":"Microbes Infect"},{"issue":"9","key":"10.1016\/j.vaccine.2012.12.071_bib0035","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1128\/IAI.73.9.5842-5852.2005","article-title":"Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL\/6 mice but does not prevent progressive disease in BALB\/c mice","volume":"73","author":"Iborra","year":"2005","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2012.12.071_bib0040","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.20020147","article-title":"Vaccination with heat-killed Leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against Leishmania major infection","volume":"195","author":"Rhee","year":"2002","journal-title":"J Exp Med"},{"issue":"24","key":"10.1016\/j.vaccine.2012.12.071_bib0045","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1093\/nar\/25.24.4872","article-title":"A new nomenclature for the cytoplasmic ribosomal proteins of Saccharomyces cerevisiae","volume":"25","author":"Mager","year":"1997","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.vaccine.2012.12.071_bib0050","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2144\/97236bm15","article-title":"Recovery of soluble, active recombinant protein from inclusion bodies","volume":"23","author":"Shi","year":"1997","journal-title":"BioTech"},{"issue":"12","key":"10.1016\/j.vaccine.2012.12.071_bib0055","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1128\/CVI.00295-09","article-title":"Specific serodiagnosis of canine visceral leishmaniasis using Leishmania species ribosomal protein extracts","volume":"16","author":"Coelho","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2012.12.071_bib0060","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1046\/j.1365-2249.1999.00796.x","article-title":"Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis","volume":"115","author":"Soto","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2012.12.071_bib0065","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2249.1995.tb03661.x","article-title":"During active viscerocutaneous leishmaniasis the anti-P2 humoral response is specifically triggered by the parasite P proteins","volume":"100","author":"Soto","year":"1995","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2012.12.071_bib0070","doi-asserted-by":"crossref","first-page":"e712","DOI":"10.1371\/journal.pntd.0000712","article-title":"Immunity to Lutzomyia intermedia saliva modulates the inflammatory environment induced by Leishmania braziliensis","volume":"4","author":"de Moura","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2012.12.071_bib0075","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1128\/AAC.39.9.2167","article-title":"Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice","volume":"39","author":"Buffet","year":"1995","journal-title":"Antimicrob Agents Chemoter"},{"issue":"5","key":"10.1016\/j.vaccine.2012.12.071_bib0080","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1128\/IAI.62.5.1643-1651.1994","article-title":"Antigens shared by Leishmania species and Trypanosoma cruzi: immunological comparison of the acidic ribosomal P0 proteins","volume":"62","author":"Skeiky","year":"1994","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2012.12.071_bib0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0165-2478(95)02436-0","article-title":"Identification of the Leishmania infantum P0 ribosomal protein epitope in canine visceral leishmaniasis","volume":"48","author":"Soto","year":"1995","journal-title":"Immunol Lett"},{"issue":"4","key":"10.1016\/j.vaccine.2012.12.071_bib0090","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1645\/GE-3297RN","article-title":"Molecular characterization of the Leishmania braziliensis L6 ribosomal protein","volume":"90","author":"Thomas","year":"2004","journal-title":"J Parasitol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.12.071_bib0095","doi-asserted-by":"crossref","first-page":"e1430","DOI":"10.1371\/journal.pntd.0001430","article-title":"Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach","volume":"6","author":"Coelho","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"3-4","key":"10.1016\/j.vaccine.2012.12.071_bib0100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vetpar.2008.10.097","article-title":"Distinct antigen recognition pattern during zoonotic visceral leishmaniasis in humans and dogs","volume":"160","author":"Goto","year":"2009","journal-title":"Vet Parasitol"},{"issue":"14","key":"10.1016\/j.vaccine.2012.12.071_bib0105","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.vaccine.2005.12.012","article-title":"From genome to vaccines for leishmaniasis: screening 100 novel vaccine candidates against murine Leishmania major infection","volume":"24","author":"Stober","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2012.12.071_bib0110","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1128\/CVI.00413-07","article-title":"Coencapsulation of CpG oligodeoxynucleotides with recombinant Leishmania major stress-inducible protein 1 in liposome enhances immune response and protection against leishmaniasis in immunized BALB\/c mice","volume":"15","author":"Badiee","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2012.12.071_bib0115","first-page":"ID173039","article-title":"Searching genes encoding Leishmania antigens for diagnosis and protection","volume":"2009","author":"Soto","year":"2009","journal-title":"Sch Res Exch"},{"issue":"9","key":"10.1016\/j.vaccine.2012.12.071_bib0120","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1128\/IAI.73.9.5827-5834.2005","article-title":"Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis","volume":"73","author":"de Moura","year":"2005","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2012.12.071_bib0125","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1128\/CVI.00060-07","article-title":"Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World","volume":"14","author":"Salay","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2012.12.071_bib0130","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4269\/ajtmh.2007.76.579","article-title":"Cross-protection against Leishmania donovani but not L. braziliensis caused by vaccination with L. major soluble promastigote exogenous antigens in BALB\/c mice","volume":"76","author":"Tonui","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2012.12.071_bib0135","first-page":"2115","article-title":"Towards development of novel immunization strategies against leishmaniasis using PLGA nanoparticles loaded with kinetoplastid membrane protein-11","volume":"7","author":"Santos","year":"2012","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"10.1016\/j.vaccine.2012.12.071_bib0140","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1084\/jem.173.1.49","article-title":"A mouse model of Leishmania braziliensis braziliensis infection produced by coinjection with sand fly saliva","volume":"173","author":"Samuelson","year":"1991","journal-title":"J Exp Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12018580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12018580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T05:04:43Z","timestamp":1595221483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12018580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0264410X12018580"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.12.071","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}